Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood
- Technische Universität Dresden, Germany
- University Clinic Carl Gustav Carus, Technische Universität Dresden, Germany
- University of Glasgow, United Kingdom
- Karolinska Institutet, Sweden
- University of Cambridge, United Kingdom
Abstract
Blood is arguably the most important bodily fluid and its analysis provides crucial health status information. A first routine measure to narrow down diagnosis in clinical practice is the differential blood count, determining the frequency of all major blood cells. What is lacking to advance initial blood diagnostics is an unbiased and quick functional assessment of blood that can narrow down the diagnosis and generate specific hypotheses. To address this need, we introduce the continuous, cell-by-cell morpho-rheological (MORE) analysis of diluted whole blood, without labeling, enrichment or separation, at rates of 1,000 cells/sec. In a drop of blood we can identify all major blood cells and characterize their pathological changes in several disease conditions in vitro and in patient samples. This approach takes previous results of mechanical studies on specifically isolated blood cells to the level of application directly in blood and adds a functional dimension to conventional blood analysis.
Data availability
-
Data from: Detection of human disease conditions by single-cell morpho-rheological phenotyping of whole bloodAvailable at Dryad Digital Repository under a CC0 Public Domain Dedication.
Article and author information
Author details
Funding
Alexander von Humboldt-Stiftung (Alexander von Humboldt Professorship)
- Jochen Guck
National Institute for Health Research (Cambridge Biomedical Research Centre)
- Edwin R Chilvers
GlaxoSmithKline (noncommercial grant)
- Edwin R Chilvers
Seventh Framework Programme (ERC Starting Grant #282060)
- Jochen Guck
Deutsche Forschungsgemeinschaft (TRR83 and SFB655)
- Ünal Coskun
- Martin Bornhäuser
Seventh Framework Programme (ITN)
- Lisa Ranford-Cartwright
- Birgitta Henriques Normark
- Jochen Guck
Bundesministerium für Bildung und Forschung (German Center for Diabetes Research (DZD e.V.))
- Ünal Coskun
Sächsisches Staatsministerium für Wissenschaft und Kunst (TG70 AZ 4-7531.60/29/45)
- Oliver Otto
- Jochen Guck
Tour der Hoffnung (noncommercial grant)
- Julia Stächele
Sonnenstrahl e.V. Dresden (noncommercial grant)
- Meinolf Suttorp
Center for Regenerative Therapies Dresden (Seed grant FZ 111)
- Jochen Guck
Technische Universität Dresden (Support the Best Program)
- Reinhard Berner
- Jochen Guck
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Patricia Bassereau, Institut Curie, France
Ethics
Human subjects: The work involved measurements of human blood samples. All studies complied with the Declaration of Helsinki and involved written informed consent from all participants or their legal guardians. Ethics for experiments with human blood were approved by the ethics committee of the Technische Universität Dresden (EK89032013, EK458102015), and for human blood and LPS inhalation in healthy volunteers by the East of England, Cambridge Central ethics committee (Study No. 06/Q0108/281 and ClinicalTrialReference NCT02551614).
Version history
- Received: June 1, 2017
- Accepted: January 3, 2018
- Accepted Manuscript published: January 13, 2018 (version 1)
- Version of Record published: January 30, 2018 (version 2)
Copyright
© 2018, Toepfner et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 6,917
- views
-
- 847
- downloads
-
- 118
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood
eLife 7:e29213.
https://doi.org/10.7554/eLife.29213
Further reading
-
- Structural Biology and Molecular Biophysics
Bacteria utilize various strategies to prevent internal dehydration during hypertonic stress. A common approach to countering the effects of the stress is to import compatible solutes such as glycine betaine, leading to simultaneous passive water fluxes following the osmotic gradient. OpuA from Lactococcus lactis is a type I ABC-importer that uses two substrate-binding domains (SBDs) to capture extracellular glycine betaine and deliver the substrate to the transmembrane domains for subsequent transport. OpuA senses osmotic stress via changes in the internal ionic strength and is furthermore regulated by the 2nd messenger cyclic-di-AMP. We now show, by means of solution-based single-molecule FRET and analysis with multi-parameter photon-by-photon hidden Markov modeling, that the SBDs transiently interact in an ionic strength-dependent manner. The smFRET data are in accordance with the apparent cooperativity in transport and supported by new cryo-EM data of OpuA. We propose that the physical interactions between SBDs and cooperativity in substrate delivery are part of the transport mechanism.
-
- Structural Biology and Molecular Biophysics
Regulated hydrolysis of the phosphoinositide phosphatidylinositol(4,5)-bis-phosphate to diacylglycerol and inositol-1,4,5-P3 defines a major eukaryotic pathway for translation of extracellular cues to intracellular signaling circuits. Members of the lipid-activated protein kinase C isoenzyme family (PKCs) play central roles in this signaling circuit. One of the regulatory mechanisms employed to downregulate stimulated PKC activity is via a proteasome-dependent degradation pathway that is potentiated by peptidyl-prolyl isomerase Pin1. Here, we show that contrary to prevailing models, Pin1 does not regulate conventional PKC isoforms α and βII via a canonical cis-trans isomerization of the peptidyl-prolyl bond. Rather, Pin1 acts as a PKC binding partner that controls PKC activity via sequestration of the C-terminal tail of the kinase. The high-resolution structure of full-length Pin1 complexed to the C-terminal tail of PKCβII reveals that a novel bivalent interaction mode underlies the non-catalytic mode of Pin1 action. Specifically, Pin1 adopts a conformation in which it uses the WW and PPIase domains to engage two conserved phosphorylated PKC motifs, the turn motif and hydrophobic motif, respectively. Hydrophobic motif is a non-canonical Pin1-interacting element. The structural information combined with the results of extensive binding studies and experiments in cultured cells suggest that non-catalytic mechanisms represent unappreciated modes of Pin1-mediated regulation of AGC kinases and other key enzymes/substrates.
